Emanuel Björne

Emanuel Björne has a diverse work experience spanning over several industries and roles. Emanuel began their career as a Healthcare Specialist in the Swedish Airforce, where they were responsible for emergency and out-patient care. Emanuel then worked as a Team Manager at McCann, leading event marketing productions for various companies.

In 2004, Björne became an Analytical Chemist at PolyPeptide Group and later transitioned to the role of Research Analyst at Biolin Scientific AB in 2006.

Emanuel'scareer took a significant turn in 2007 when they became the Chief Executive Officer of Hansa Biopharma AB (publ), a start-up in the healthcare industry. During their tenure as CEO, they raised SEK170 million through an IPO and four follow-ons at NASDAQ First North.

From 2014 to 2019, Björne held the positions of Vice President Investor Relations & Business Development, as well as Vice President Business Development & Alliance Management at Hansa Biopharma AB. Emanuel'sresponsibilities included developing and commercializing antibody eliminating enzymes for transplantation, autoimmunity, and pre-treatment prior to cell & gene therapy.

Overall, Emanuel Björne's work experience reflects a strong background in healthcare, business development, and leadership roles.

Emanuel Björne has a diverse education history spanning multiple fields of study. In 1996-1997, they attended Lund University where they focused on Mathematics, Media and Communication, and Cell Biology. Following this, from 1997 to 2001, they pursued a degree in Engineering Physics and Molecular Biophysics at The Faculty of Engineering at Lund University. Emanuel'sacademic journey continued at UC Santa Barbara from 2001 to 2002, where they obtained a Master of Science degree in Molecular Biophysics.